The burgeoning field ofinvestigations into novel anxiolytics is rapidly expanding, with untapped research chemicals showing encouraging results in preclinical and clinical experiments. These molecules often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential improvements for subjects struggling